These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 20795453)
1. Lupoid leishmaniasis due to Leishmania major with remaining large scars: report of 2 cases. Sadeghian G; Ziaei H; Shirani-Bidabadi L; Nilforoushzadeh MA East Mediterr Health J; 2010 Mar; 16(3):344-5. PubMed ID: 20795453 [No Abstract] [Full Text] [Related]
2. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis. Moosavi Z; Nakhli A; Rassaii S Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282 [No Abstract] [Full Text] [Related]
3. Infiltrated leishmaniasis recidivans cutis on the face: a rare clinical presentation. Masood S; Naveed S; Alvi RU Trop Doct; 2012 Apr; 42(2):120-1. PubMed ID: 22337728 [TBL] [Abstract][Full Text] [Related]
4. Mutilating lupoid leishmaniasis: twelve years to make the diagnosis! Ghosn S; Dahdah MJ; Kibbi AG Dermatology; 2008; 216(2):187-9. PubMed ID: 18216488 [No Abstract] [Full Text] [Related]
5. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran. Alborzi A; Pouladfar GR; Fakhar M; Motazedian MH; Hatam GR; Kadivar MR Am J Trop Med Hyg; 2008 Sep; 79(3):435-7. PubMed ID: 18784238 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children. Layegh P; Pezeshkpoor F; Soruri AH; Naviafar P; Moghiman T Am J Trop Med Hyg; 2009 Feb; 80(2):172-5. PubMed ID: 19190206 [TBL] [Abstract][Full Text] [Related]
7. Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis. Pourmohammadi B; Motazedian MH; Handjani F; Hatam GH; Habibi S; Sarkari B Southeast Asian J Trop Med Public Health; 2011 May; 42(3):502-8. PubMed ID: 21706927 [TBL] [Abstract][Full Text] [Related]
8. Cutaneous leishmaniasis with pseudoepitheliomatous hyperplasia simulating squamous cell carcinoma. Quintella LP; Cuzzi T; de Fátima Madeira M; Valete-Rosalino CM; de Matos Salgueiro M; de Camargo Ferreira e Vasconcellos E; Mouta-Confort E; Lambert Passos SR; de Oliveira Schubach A Am J Dermatopathol; 2011 Aug; 33(6):642-4. PubMed ID: 21778837 [No Abstract] [Full Text] [Related]
9. [A Pediatric case of lupoid leishmaniasis diagnosed by PCR]. Paradisi M; Grosso MG; Angelo C; Gradoni L; Ludovisi A; N'Doni F; Puddu P Minerva Pediatr; 2001 Feb; 53(1):33-7. PubMed ID: 11419394 [TBL] [Abstract][Full Text] [Related]
10. Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis. Salmanpour R; Razmavar MR; Abtahi N Int J Dermatol; 2006 Sep; 45(9):1115-6. PubMed ID: 16961529 [No Abstract] [Full Text] [Related]
11. [Sporotrichoid cutaneous leishmaniasis]. López-Escobar M; Drake-Monfort M; Salesa-Gutiérrez de Rozas R; Hermana-Ramírez S Actas Dermosifiliogr; 2007; 98(6):444-5. PubMed ID: 17663940 [No Abstract] [Full Text] [Related]
12. [Clinical, epidemiological and evolutionary aspects in 157 cases of cutaneous leishmaniasis in Morocco]. Hjira N; Frikh R; Marcil T; Lamsyah H; Oumakhir S; Baba N; Boui M Pan Afr Med J; 2014; 17():272. PubMed ID: 25309671 [TBL] [Abstract][Full Text] [Related]
13. Lupoid cutaneous leishmaniasis: a report of 16 cases. Ul Bari A; Raza N Indian J Dermatol Venereol Leprol; 2010; 76(1):85. PubMed ID: 20061750 [TBL] [Abstract][Full Text] [Related]
14. [Infiltrated plaque on the lip]. Litaiem N; Jaber K; El Khalifa J; Kaabi W; Soumaya Y; Dhaoui MR; Doss N Ann Dermatol Venereol; 2013; 140(8-9):547-8. PubMed ID: 24034642 [No Abstract] [Full Text] [Related]
15. Cutaneous lupoid leishmaniasis: a case report. Ferahbaş A; Mistik S; Utaş S; Yaman O; Canoz O; Doganay M; Aşçioglu O Cutis; 2006 Jan; 77(1):25-8; quiz 37-8. PubMed ID: 16475491 [TBL] [Abstract][Full Text] [Related]
16. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran. Mohebali M; Fotouhi A; Hooshmand B; Zarei Z; Akhoundi B; Rahnema A; Razaghian AR; Kabir MJ; Nadim A Acta Trop; 2007 Jul; 103(1):33-40. PubMed ID: 17586452 [TBL] [Abstract][Full Text] [Related]
17. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major. Shazad B; Abbaszadeh B; Khamesipour A Eur J Dermatol; 2005; 15(2):85-7. PubMed ID: 15757817 [TBL] [Abstract][Full Text] [Related]